TNF-α and IL-4 regulate expression of IL-13 receptor α2 on human fibroblasts

Biochemical and Biophysical Research Communications

Volumn 312, Issue 4, 2003, Pages 1248-1255

  Yoshikawa, Mamoru ^a,b   Nakajima, Toshiharu ^a   Tsukidate, Toshiharu ^a,b   Matsumoto, Kenji ^a   Iida, Makoto ^b   Otori, Nobuyoshi ^b   Haruna, Shin Ichi ^b   Moriyama, Hiroshi ^b   Saito, Hirohisa ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Decoy receptor; Human fibroblast; IL 13R 2; IL 4; Mobilization; TNF

Indexed keywords

BREFELDIN A; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; PROTEIN SUBUNIT; STAT6 PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; FETUS; FIBROBLAST; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; REGULATORY MECHANISM;

EID: 0345357710     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.077     Document Type: Article

References (42)

1. Zurawski S.M., Vega F.J., Huyghe B., Zurawski G. Receptors for interleukine-13 and interleukine-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12:1993;2663-2670.
2. Minty A., Chalon P., Derocq J.M., Dumont X., Guillemot J.C., Kaghad M., Labit C., Leplatois P., Liauzun P., Miloux B. Interleukine-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 362:1993;248-250.
3. Lebman D.A., Coffman R.L. Interleukine-4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures. J. Exp. Med. 168:1988;853-862.
4. Pene J., Rousset F., Briere F., Chretien I., Bonnefoy J.Y., Spits H., Yokota T., Arai N., Arai K., Banchereau J., de Vries J.E. IgE production by normal human lymphocytes is induced by interleukine 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc. Natl. Acad. Sci. USA. 85:1988;6880-6884.
5. Punnonen J., Aversa G., Cocks B.G., McKenzie A.N., Menon S., Zurawski G., Malefyt R.dW., de Vries J.E. Interleukine 13 induces interleukine 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA. 90:1993;3730-3734.
6. Defrance T., Carayon P., Billian G., Guillemot J.C., Minty A., Caput D., Ferrara P. Interleukine 13 is a B cell stimulating factor. J. Exp. Med. 179:1994;135-143.
7. McKenzie A.N., Culpepper J.A., Malefyt R.dW., Briere F., Punnonen J., Aversa G., Sato A., Dang W., Cocks B.G., Menon S., de Varis J.E. Interleukine 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. USA. 90:1993;3735-3739.
8. Malefyt R.dW., Figdor C.G., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J., Dang W., Zurawski G., de Vries J.E. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J. Immunol. 151:1993;6370-6381.
9. Malefyt R.dW., Figdor C.G., de Vries J.E. Effects of interleukine 4 on monocyte functions: comparison to interleukine 13. Res. Immunol. 144:1993;629-633.
10. Bochner B.S., Klunk D.A., Sterbinsky S.A., Coffman R.L., Schleimer R.P. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J. Immunol. 154:1995;799-803.
11. Sironi M., Sciacca F.L., Matteucci C., Conni M., Vecchi A., Bernasconi S., Minty A., Caput D., Ferrara P., Colotta F. Regulation of endothelial and mesothelial cell function by interleukine-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukine-6 production. Blood. 84:1994;1913-1921.
12. Schnyder B., Lugli S., Feng N., Etter H., Lutz R.A., Ryffel B., Sugamira K., Wunderli-Allenspach H., Moser R. Interleukine-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood. 87:1996;4286-4295.
13. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M.E., Lobb R.R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 60:1990;577-584.
14. Aman M.J., Tayebi N., Obiri N.I., Puri R.K., Modi W.S., Leonard W.J. cDNA cloning and characterization of the human interleukine 13 receptor alpha chain. J. Biol. Chem. 271:1996;29265-29270.
15. Caput D., Laurent P., Kaghad M., Lelias J.M., Lefort S., Vita N., Ferrara P. Cloning and characterization of a specific interleukine (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J. Biol. Chem. 271:1996;16921-16926.
16. Hilton D.J., Zhang J.G., Metcalf D., Alexander W.S., Nicola N.A., Willson T.A. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA. 93:1996;497-501.
17. Obiri N.I., Debinski W., Leonard W.J., Puri R.K. Receptor for interleukine 13. J. Biol. Chem. 270:1995;8797-8804.
18. Jiang H., Harris M.B., Rothman P. IL-4/IL-13 signaling beyond JAK/STAT. J. Allergy Clin. Immunol. 105:2000;1063-1070.
19. Ogata H., Ford D., Kouttab N., King T.C., Vita N., Minty A., Stoeckler J., Morgan D., Girasole C., Morgan J.W., Maizel A.L. Regulation of interleukin-13 receptor constituents on mature human B lymphocytes. J. Biol. Chem. 273:1998;9864-9871.
20. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., Giri J.G., Dower S.K., Sims J.E., Mantovani A. Interleukine-1 type II receptor: a decoy receptor for IL-1 that is regulated by IL-4. Science. 261:1993;472-475.
21. Donaldson D.D., Whitters M.J., Fitz L.J., Neben T.Y., Finnerty H., Henderson S.L., O'Hara R.M. Jr., Beier D.R., Turner K.J., Wood C.R., Collins M. The murine IL-13 receptor α2: molecular cloning, characterization, and comparison with murine IL-13 receptor α1. J. Immunol. 161:1998;2317-2324.
22. Feng N., Lugli S.M., Schnyder B., Gauchat J-F.M., Graber P., Schlagenhauf E., Schnarr B., Wiederkehr-Adam M., Duschl A., Heim M.H., Lutz R.A., Moser R. The interleukine-4/interleukine-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukine-13 receptor α2. Lab. Invest. 78:1998;591-602.
23. Bernard J., Treton D., Vermot-Desroches C., Boden C., Horellou P., Angevin E., Galanaud P., Wijdenes J., Richard Y. Expression of interleukine 13 receptor in glioma and renal cell carcinoma: IL13Rα2 as a decoy receptor for IL13. Lab. Invest. 81:2001;1223-1231.
24. Danes M.O., Hershey G.K.K. A novel mechanism by which interferon-γ can regulate interleukin (IL)-13 responses: evidence for intracellular stores of IL-13 receptor α-2 and their rapid mobilization by interferon-γ J. Biol. Chem. 277:2002;10387-10393.
25. Terada N., Hamano N., Nomura T., Numata T., Hirai K., Nakajima T., Yamada H., Yoshie O., Ikeda-Ito T., Konno A. Interleukine-13 and tumour necrosis factor-α synergistically induce eotaxin production in human nasal fibroblasts. Clin. Exp. Allergy. 30:2000;348-355.
26. Doucet C., Brouty-Boye D., Pottin-Clemenceau C., Jasmin C., Canonica G.W., Azzarone B. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int. Immunol. 10:1998;1421-1433.
27. Doucet C., Brouty-Boye D., Pottin-Clemenceau C., Canonica G.W., Jasmin C., Azzarone B. Interleukine (IL) 4 IL-13 act on human lung fibroblasts. J. Clin. Invest. 101:1998;2129-2139.
28. Roche W.R., Beasley R., Williams J.H., Holgate S.T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1:1989;520-523.
29. Derdak S., Penny D.P., Keng P., Felch M., Brown D., Phipps R.P. Collagen and fibronectin production by Thy 1+ and Thy 1- lung fibroblast subpopulations. Am. J. Physiol. 263:1992;L283-L290.
30. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., Zhang Y., Elias J.A. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103:1999;779-788.
31. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., Donaldson D.D. Interleukin-13: central mediator of allergic asthma. Science. 282:1998;2258-2261.
32. Grünig G., Warnock M., Wakil A.E., Venkayya R., Brombacher F., Rennick D.M., Sheppard D., Mohrs M., Donaldson D.D., Locksley R.M., Corry D.B. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 282:1998;2261-2263.
33. Rahaman S.O., Sharma P., Harbor P.C., Aman M.J., Vogelbaum M.A., Haque S.J. IL-13Rα2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells. Cancer Res. 62:2002;1103-1109.
34. Kawakami K., Taguchi J., Murata T., Puri R.K. The interleukine-13 receptor α2 chain: an essential component for binding and internalization but not for interleukine-13-induced signal transduction through the STAT6 pathway. Blood. 97:2001;2673-2679.
35. Kawakami K., Takeshita F., Puri R.K. Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukine (IL) -13 binding component IL-13 receptor α2 chain. J. Biol. Chem. 276:2001;25114-25120.
36. Wood S.A., Park J.E., Brown W.J. Brefeldin A causes a microtubule-mediated fusion of the. trans -Golgi network and early endosomes Cell. 67:1991;591-600.
37. Graves P.E., Kabesch M., Halonen M., Holberg C.J., Baldini M., Fritzsch C., Weiland S.K., Erickson R.P., von Mutius E., Martinez F.D. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J. Allergy Clin. Immunol. 105:2000;506-513.
38. Liu X., Nickel R., Beyer K., Wahn U., Ehrlich E., Freidhoff L.R., Björkstén B., Beaty T.H., Huang S.K. An IL13 coding region variant is associated with high total serum IgE level and atopic dermatitis in the German Multicenter Atopy Study (MAS-90). J. Allergy Clin. Immunol. 106:2000;167-170.
39. Gao P.S., Mao X.Q., Hopkin J.M., Adra C.N., Yang X., Shirakawa T. Functional significance of polymorphisms of the interleukin-4 and interleukin-13 receptors in allergic disease. Clin. Exp. Allergy. 30:2000;1672-1675.
40. Celedón J.C., Soto-Quiros M.E., Palmer L.J., Senter J., Mosley J., Silverman E.K., Weiss S.T. Lack of association between a polymorphism in the interleukin-13 gene and total serum immunoglobulin E level among nuclear families. Clin. Exp. Allergy. 32:2002;387-390.
41. Heinzmann A., Mao X-Q., Akaiwa M., Kreomer R.T., Gao P.S., Ohshima K., Umeshita R., Abe Y., Braun S., Yamashita T., Roberts M.H., Sugimoto R., Arima K., Arinobu Y., Yu B., Kruse S., Enomoto T., Dake Y., Kawai M., Shimazu S., Sasaki S., Adra C.N., Kitaichi M., Inoue H., Yamauchi K., Tomichi N., Kurimoto F., Hamasaki N., Hopkin J.M., Izuhara K., Shirakawa T., Deichmann K.A. Genetic variants of IL-13 signalling and human asthma and atopy. Hum. Mol. Genet. 9:2000;549-559.
42. Howard T.D., Whittaker P.A., Zaiman A.L., Koppelman G.H., Xu J., Hanley M.T., Meyers D.A., Postma D.S., Bleecker E.R. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am. J. Respir. Cell Mol. Biol. 25:2001;377-384.